Sponsor pipeline

Korea Otsuka Pharmaceutical Co., Ltd. clinical trial pipeline

1 active trials 0 recruiting 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-17

What changed in the last 30 days

2026-09-06

Trial status changed: Recruiting → Unknown

NCT03423680 A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar… · Phase 3

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not specified
NCT06674291	Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in…	Tuberculosis, Multidrug-Resistant	Not Yet Recruiting	2024-11-05

Get alerts when Korea Otsuka Pharmaceutical Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.